Lupin is a global pharmaceutical company offering a wide range of products including branded and generic formulations, Active Pharmaceutical Ingredients (APIs), biotechnology products and speciality medicines.
This website page is targeted to a wide range of audiences
This link will take you to a non-Lupin UK website. Lupin does not recommend, endorse or accept liability for sites controlled by third-parties.
This link will take you to another Lupin Healthcare UK provided website.
Lupin is a global pharmaceutical company offering a wide range of products including branded and generic formulations, Active Pharmaceutical Ingredients (APIs), biotechnology products and speciality medicines.
With a presence in over 100 countries, Lupin offers high-quality yet affordable medicines for some of the most chronic diseases addressing unmet needs in many parts of the world.
Novel drug discovery and development in oncology, immunology and metabolic disorders, partnering with global pharma companies like Abbvie and Boehringer in novel drug development.
Lupin has a significant presence in the therapy areas of Gynaecology, Cardiovascular, Diabetes, Asthma, Paediatrics, Central Nervous System (CNS), Gastrointestinal (GI), Anti-Infective (AI) and Non-Steroidal
Anti-Inflammatory Drugs (NSAIDs).
1. Lupin Ltd. Investor presentation FY 2021-22. https://www.lupin.com/wp-content/uploads/2022/05/lupin-investor-presentation-fy2021-22.pdf. Accessed: Jan 2023.